KINTAI Biotech Publishes Guide on Stephania Tetrandra Root Extract
KINTAI Biotech has released a guide for global buyers outlining seven key insights on Stephania Tetrandra root extract. The guide covers the product's properties, traditional uses, and quality assessment.
KINTAI Biotech Inc. has published a guide providing global buyers with seven essential insights into Stephania Tetrandra root extract. The extract, derived from a perennial herb native to China, has gained attention for its traditional medicinal uses and increasing demand in the natural products market.
The company states the guide details the extract's traditional applications, key benefits, and quality indicators for assessment. It also offers guidance on sourcing strategies and ensuring product quality throughout the supply chain, from planting to the final product.
The publication addresses legal and regulatory considerations for importing herbal extracts and discusses emerging market trends. KINTAI Biotech emphasizes its commitment to quality assurance through stringent inspection protocols covering the entire supply chain.
Stephania Tetrandra contains active compounds such as alkaloids, flavonoids, and saponins. Research published in the Journal of Ethnopharmacology suggests these compounds possess anti-inflammatory and analgesic effects, indicating potential therapeutic roles in managing chronic pain and inflammatory conditions.